Trial: 201905156

A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma

Phase

III

Principal Investigator

Ansstas, George

Disease Site

Other Skin

Learn more about this study at: clinicaltrials.gov